Search results for "Serum potassium"

showing 5 items of 5 documents

Massive digoxin intoxication in childhood.

1978

In a 10 year old boy 8 hours after taking about 16 mg beta-acetyl-digoxin a maximum serum digoxin level of 31.8 ng/ml was measured radioimmunologically. This is the highest digitalis level in childhood described to date. The serum potassium level rose to 7.4 mmol/l. Complete atrio-ventricular block, and salves of ventricular premature beats were the most serious rhythm disturbances. The absence of life threatening rhythm disturbances is attributed to the early use of diphenylhydantoin in small frequent doses.

MaleDigoxinInjury controlAccident preventionPhysiologyPoison controlSuicide AttemptedCritical Care and Intensive Care MedicineDigitalis levelElectrocardiographypolycyclic compoundsMedicineHumanscardiovascular diseasesChildbusiness.industrydigestive oral and skin physiologySerum digoxin levelcarbohydrates (lipids)Heart BlockAnesthesiaPhenytoinPotassiumDigoxin intoxicationbusinessSerum potassium levelIntensive care medicine
researchProduct

Red blood cell sodium and potassium after hydrochlorothiazide.

1981

In six of seven healthy males 6 days of hydrochlorothiazide (HCT), 50 mg twice daily, without potassium supplements resulted in a rise in red blood cell (RBC) sodium concentration. Serum potassium concentration fell in all subjects. Four days after discontinuing HCT, intracellular sodium and extracellular potassium concentrations had normalized. Throughout the evaluation period the course of mean relative intracellular sodium was almost a mirror image of mean relative extracellular potassium. Thus, either the decline of serum potassium or of HCT (because of its inhibitory effect on Na-K-ATPase activity) might have diminished Na-K-ATPase–dependent active RBC sodium efflux with a resultant ri…

PharmacologyIntracellular sodiumMaleErythrocytesTime FactorsPotassiumSodiumSodiumchemistry.chemical_elementPharmacologyRed blood cellHydrochlorothiazidemedicine.anatomical_structureHydrochlorothiazidechemistrySerum potassiummedicinePotassiumHumansPharmacology (medical)EffluxInhibitory effectmedicine.drugClinical pharmacology and therapeutics
researchProduct

Änderungen des Elektrolytgehaltes von Erythrozyten und Plasma bei nephrektomierten Ratten

1957

After two-stage nephrectomy in rats the potassium concentration in the red blood corpuscles (RBC) decreases from 10.6 ± 0.3 to 5.5 ± 0.3 mEq per 100 ml of RBC within 48 h. The decrease is accompanied by a much smaller increase in the plasma potassium concentration; the hyperkaliemia in nephrectomized rats is less pronounced than in nephrectomized dogs or anuric humans. Na+ in RBC increases by about 44% after nephrectomy; while there is only a very slight decrease of Na+ in plasma. Plasma chlorides drop from 10.92 ± 0.08 mEq/100 ml of plasma to 6.00 ± 0.81 mEq % within 48 h after nephrectomy. RBC chlorides tend to increase again after an initial drop from 5.22 ± 0.07 to 3.82 ± 0.90 mEq% with…

Pharmacologymedicine.medical_specialtyChemistrymedicine.medical_treatmentPotassiumchemistry.chemical_elementCell BiologyNephrectomyCellular and Molecular NeuroscienceEndocrinologySerum potassiumBiochemistryInternal medicinemedicineMolecular MedicineBlood corpusclesMolecular BiologyExperientia
researchProduct

Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial

2021

Abstract Aims  Hyperkalaemia is a common complication of type 2 diabetes mellitus (T2DM) and limits the optimal use of agents that block the renin–angiotensin–aldosterone system, particularly in patients with chronic kidney disease (CKD). In patients with CKD, sodium‒glucose cotransporter 2 (SGLT2) inhibitors provide cardiorenal protection, but whether they affect the risk of hyperkalaemia remains uncertain. Methods and results  The CREDENCE trial randomized 4401 participants with T2DM and CKD to the SGLT2 inhibitor canagliflozin or matching placebo. In this post hoc analysis using an intention-to-treat approach, we assessed the effect of canagliflozin on a composite outcome of time to eith…

medicine.medical_specialtyCardiac & Cardiovascular SystemsINHIBITIONRATIONALEPlaceboHYPERKALEMIAMECHANISMSHyperkalaemiaChronic kidney diseaseInternal medicineDiabetes mellitusType 2 diabetes mellitusEND-POINTSPost-hoc analysismedicineHumansCanagliflozinRenal Insufficiency Chronic1102 Cardiorespiratory Medicine and HaematologySodium-Glucose Transporter 2 InhibitorsCanagliflozinOUTCOMESScience & Technologybusiness.industryType 2 Diabetes Mellitus1103 Clinical Sciencesmedicine.diseaseCardiovascular System & HematologyDiabetes Mellitus Type 2Serum potassiumCardiovascular System & CardiologyPotassiumCardiology and Cardiovascular MedicinebusinessComplicationLife Sciences & BiomedicineSGLT2 inhibitorsKidney diseasemedicine.drugEuropean Heart Journal
researchProduct

�nderungen des Elektrolytgehalts von Erythrocyten und Plasma bei nephrektomierten Ratten

1957

After two-stage nephrectomy in rats the potassium concentration in the red blood corpuscles (RBC) decreases from 10.6 ± 0.3 to 5.5 ± 0.3 mEq per 100 ml of RBC within 48 h. The decrease is accompanied by a much smaller increase in the plasma potassium concentration; the hyperkaliemia in nephrectomized rats is less pronounced than in nephrectomized dogs or anuric humans. Na+ in RBC increases by about 44% after nephrectomy; while there is only a very slight decrease of Na+ in plasma. Plasma chlorides drop from 10.92 ± 0.08 mEq/100 ml of plasma to 6.00 ± 0.81 mEq % within 48 h after nephrectomy. RBC chlorides tend to increase again after an initial drop from 5.22 ± 0.07 to 3.82 ± 0.90 mEq% with…

medicine.medical_specialtyKidneyChemistrymedicine.medical_treatmentPotassiumchemistry.chemical_elementGeneral MedicineElectrolyteNephrectomyEndocrinologymedicine.anatomical_structureSerum potassiumInternal medicineDrug DiscoverymedicineMolecular MedicineWater-Electrolyte BalanceBlood corpusclesGenetics (clinical)Klinische Wochenschrift
researchProduct